References
- Krenzelok EP. Aspects of Datura poisoning and treatment. Clin Toxicol 2010; 48:104–110.
- Schneir AB, Offerman SR, Ly BT, Davis JM, Baldwin RT, Williams SR, Clark RF. Complications of diagnostic physostigmine administration to emergency department patients. Ann Emerg Med 2003; 42:14–19.
- Burns MJ, Linden CH, Graudins A, Brown RM, Fletcher KE. A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning. Ann Emerg Med 2000; 35: 347–381.
- Donovan JW. Anticholinergic plants. In: Brent J, Wallace KL, Burkhart KK, Phillips SD, Donovan JW, eds. Critical Care Toxicology: Diagnosis and Management of the Critically Poisoned Patient. Philadelphia: Elsevier Mosby; 2005.
- Levy R. Jimson seed poisoning—a new hallucinogen on the horizon. JACEP 1977; 6:58–61.
- Klein-Schwartz W, Oderda GM. Jimsonweed intoxication in adolescents and young adults. Am J Dis Child 1984; 138:737–739.
- Ceha LJ, Presperin C, Young E, Allswede M, Erickson T. Anticholinergic toxicity from nightshade berry poisoning responsive to physostigmine. J Emerg Med 1997; 15:65–69.
- Burkhart KK, Magalski AE, Donovan JW. A retrospective review of the use of activated charcoal and physostigmine in the treatment of jimson weed poisoning. J Tox Clin Tox 1999; 7:389.